ATE105480T1 - Thrombin bindende substanz und verfahren zu ihrer herstellung. - Google Patents

Thrombin bindende substanz und verfahren zu ihrer herstellung.

Info

Publication number
ATE105480T1
ATE105480T1 AT8989115272T AT89115272T ATE105480T1 AT E105480 T1 ATE105480 T1 AT E105480T1 AT 8989115272 T AT8989115272 T AT 8989115272T AT 89115272 T AT89115272 T AT 89115272T AT E105480 T1 ATE105480 T1 AT E105480T1
Authority
AT
Austria
Prior art keywords
thrombin
binding substance
binding
conditions
production
Prior art date
Application number
AT8989115272T
Other languages
English (en)
Inventor
Nobuo Aoki
Shigeru Kimura
Masami Shiratsuchi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE105480T1 publication Critical patent/ATE105480T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT8989115272T 1988-08-29 1989-08-18 Thrombin bindende substanz und verfahren zu ihrer herstellung. ATE105480T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP21413988 1988-08-29
JP11647189 1989-05-10
JP1202027A JPH0720997B2 (ja) 1988-08-29 1989-08-03 新規なトロンビン結合性物質及びその製法
EP89115272A EP0356836B1 (de) 1988-08-29 1989-08-18 Thrombin bindende Substanz und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE105480T1 true ATE105480T1 (de) 1994-05-15

Family

ID=27313158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT8989115272T ATE105480T1 (de) 1988-08-29 1989-08-18 Thrombin bindende substanz und verfahren zu ihrer herstellung.

Country Status (7)

Country Link
US (1) US5043425A (de)
EP (1) EP0356836B1 (de)
JP (1) JPH0720997B2 (de)
KR (2) KR900003207A (de)
AT (1) ATE105480T1 (de)
DE (1) DE68915226T2 (de)
ES (1) ES2056164T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
JPH03259084A (ja) * 1990-03-06 1991-11-19 Kowa Co トロンビン結合性物質の製造法
JP3180824B2 (ja) * 1991-08-30 2001-06-25 シスメックス株式会社 血液凝固試薬
US5716795A (en) * 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
US20050089543A1 (en) * 2001-02-01 2005-04-28 Weiser Mark J. Animal scent based repellent and attractant compositions
US20060083733A1 (en) * 2002-01-18 2006-04-20 Fumihide Nishio High-concentration preparation of soluble thrombomodulin
WO2008044631A1 (fr) * 2006-10-06 2008-04-17 Asahi Kasei Pharma Corporation Agent thérapeutique et/ou améliorant pour la coagulation intravasculaire disséminée
SG184699A1 (en) 2007-03-23 2012-10-30 Asahi Kasei Pharma Corp Method for producing high-purity soluble thrombomodulin
JP2011178687A (ja) * 2010-02-26 2011-09-15 Kochi Univ 造血細胞移植に伴う疼痛の予防および／または治療剤
EP2565269B1 (de) 2010-04-30 2016-11-16 Asahi Kasei Pharma Corporation Verfahren zur herstellung von hochreinem löslichen thrombomodulin
CN103974710B (zh) 2011-11-15 2016-07-06 旭化成制药株式会社 用于败血症的治疗和/或改善的药物
NZ702242A (en) 2012-05-31 2016-03-31 Asahi Kasei Pharma Corp Agent for prophylactic and/or therapeutic treatment of peripheral neuropathic pain caused by anticancer agent
US11497795B2 (en) 2018-09-28 2022-11-15 Asahi Kasei Pharma Corporation Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent
EP3871684B1 (de) 2018-10-22 2024-06-26 Asahi Kasei Pharma Corporation Arzneimittel zur behandlung und/oder verbesserung der septikämie in zusammenhang mit einer gerinnungsstörung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60199819A (ja) * 1984-03-23 1985-10-09 Kowa Co トロンビン結合性物質およびその製法
WO1987000050A1 (en) * 1985-06-28 1987-01-15 Asahi Kasei Kogyo Kabushiki Kaisha Novel physiologically active substance having blood coagulation controlling activity
JPH0689014B2 (ja) * 1986-01-21 1994-11-09 興和株式会社 トロンビン結合性物質およびその製法
DE3750664T2 (de) * 1986-07-15 1995-06-22 Kowa Co Throminbindende Substanz und Verfahren zu ihrer Herstellung.
JP2738428B2 (ja) * 1987-01-08 1998-04-08 旭化成工業株式会社 トロンビンによるプロテインｃの活性化を促進する作用を有するペプチド
US4912207A (en) * 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof

Also Published As

Publication number Publication date
US5043425A (en) 1991-08-27
DE68915226T2 (de) 1995-01-05
JPH0720997B2 (ja) 1995-03-08
DE68915226D1 (de) 1994-06-16
EP0356836B1 (de) 1994-05-11
EP0356836A2 (de) 1990-03-07
KR940027658A (ko) 1994-12-10
KR900003207A (ko) 1990-03-26
EP0356836A3 (en) 1990-03-28
JPH0386900A (ja) 1991-04-11
ES2056164T3 (es) 1994-10-01

Similar Documents

Publication Publication Date Title
ATE105480T1 (de) Thrombin bindende substanz und verfahren zu ihrer herstellung.
ATE59962T1 (de) Thrombin bindender stoff und verfahren zu seiner herstellung.
DE3684078D1 (de) Reinigung und aktivierung von proteinen aus unloeslichen einschlusskoerpern.
FI102836B1 (fi) Menetelmä glykosaminoglykaanilla muunnetun proteiinin valmistamiseksi
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
EP0407580A4 (en) Medical material and process for their production
DE3688760D1 (de) Expression von faktor-vii-aktivitaet in saeugetierzellen.
ES8506082A1 (es) Procedimiento para la inactivacion de germenes patogenos, capaces de reproducirse
WO1998017319A3 (en) Platelet substitutes and conjugation methods suitable for their preparation
DE3850531D1 (de) Gewebe-Plasminogenaktivator.
ATE42178T1 (de) Zusammengesetztes fleischprodukt und verfahren zu dessen herstellung.
DE3852140D1 (de) Produktion von Proteinen in aktiven Formen.
DE69736961D1 (de) Nitrilase und dafür kodierendes Polynukleotid
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
DE68911297D1 (de) Heparin bindende proteine, dafür kodierende dna, verfahren zu ihrer herstellung sowie sie enthaltende therapeutische präparate.
DE68918279D1 (de) Plasminogenaktivator-varianten und verfahren zu ihrer herstellung.
ATE113062T1 (de) Throminbindende substanz und verfahren zu ihrer herstellung.
ATE270327T1 (de) Verfahren zur präparation von humanem aktiviertem protein c
DE58903500D1 (de) Fibrin(ogen) derivate, verfahren zu ihrer herstellung und ihre vewendung.
DE59308942D1 (de) Verfahren zur Bestimmung von Fibrinogen
ES2033295T3 (es) Un metodo para preparar un activador de plasminogeno.
ATE108833T1 (de) Antikörper gegen fibrin, immunogene peptide für die herstellung dieser antikörper, verfahren zur bestimmung von fibrin und pharmazeutische zubereitungen auf der basis dieser antikörper.
NL960017I1 (nl) Expressie van Factor VIII-activiteit in zoogdiercellen.
HUT60133A (en) Process for producing protein-based pharmaceutical composition having t-pa-activity and suitable for treating blood clots
DE19881189D2 (de) Verfahren zum Herstellen von weitgehend nebenwirkungsfreien Kontrastmitteln

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee